Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38155

HNRNPA2B1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

CRISPR/Cas9-edited polyclonal HEK293T knockout cells targeting HNRNPA2B1, an RNA-binding protein regulating pre-mRNA processing, m6A modification, and innate immune signaling. This loss-of-function model enables dissection of mRNA nuclear export, alternative splicing, and translational control in a high-transfectability background. Applications include cancer biology (proliferation, metastasis), antiviral response studies, and m6A epitranscriptomic profiling using MeRIP-seq and RNA immunoprecipitation. Key molecular interactions involve XPO1-mediated nuclear export, METTL3/METTL14-dependent m6A modulation, and downstream regulation of MYC and CCND1 expression.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    HNRNPA2B1

    Gene Identifier

    NCBI Gene ID 3181

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The HNRNPA2B1 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the RNA-binding protein HNRNPA2B1. Through targeted gene disruption, this model abolishes endogenous HNRNPA2B1 expression, enabling precise dissection of its post-transcriptional regulatory roles without confounding wild-type activity.

The parental HEK293T cell line, derived from human embryonic kidney and immortalized with adenovirus 5 DNA, stably expresses the SV40 large T antigen, conferring exceptional transfectability and viral production capacity. These features make it an optimal host for analyzing gene function across diverse experimental paradigms, including transient expression and signaling assays.

HNRNPA2B1 is a nucleocytoplasmic shuttling protein that regulates pre-mRNA alternative splicing, m6A-dependent mRNA nuclear export via XPO1, and cytoplasmic translation and stability. It interacts with spliceosome components (U1/U2 snRNPs), hnRNPA1, hnRNPC, and the METTL3/METTL14 m6A methyltransferase complex. Upstream regulators include transcription factors MYC and E2F1, as well as heat shock and oxidative stress. Downstream targets encompass proliferation (MYC, CCND1), apoptosis (BCL2L1), and inflammatory (TNF) mRNAs, along with telomeric TERRA RNA. Additionally, HNRNPA2B1 senses viral nucleic acids, activating cGAS-STING-mediated innate immunity.

Ablation of HNRNPA2B1 in HEK293T cells eliminates a key node in RNA metabolism and innate immune pathways, providing a defined system for functional dissection. The polyclonal population minimizes clonal biases, and the cells’ high transfectability facilitates rescue experiments.

Researchers can apply this polyclonal knockout model to transcriptome-wide investigations of splicing and m6A modifications using RNA-seq and MeRIP-seq, cancer cell proliferation and migration assays, and innate immune studies involving viral infection and interferon induction readouts. Key techniques include RNA immunoprecipitation, co-immunoprecipitation, Western blotting, and immunofluorescence for analyzing protein?CRNA interactions and subcellular localization. Neurodegenerative disease research focusing on stress granule dynamics also benefits from this resource. For further technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)